Milwaukee Shoulder (BCP Crystal Arthropathy)

Milwaukee shoulder, also called apatite-associated destructive arthritis or basic calcium phosphate crystal arthropathy, is a rapidly destructive arthropathy of the shoulder driven by the deposition and shedding of basic calcium phosphate (BCP) crystals: principally hydroxyapatite, with carbonate-substituted apatite and octacalcium phosphate. The eponym comes from the 1981 description by McCarty and colleagues in Milwaukee. BCP crystals are recognised both as contributors to osteoarthritis and as the cause of this highly destructive shoulder arthritis.

Who. Elderly patients, with a strong female predominance: classically a woman over 70. It usually affects the dominant shoulder and may be bilateral. The knee, especially its lateral compartment, is the second classic large-joint site.

Why examiners ask about it. It is the prototypical BCP crystal disease of a large joint, and it makes the candidate integrate crystal biology, synovial fluid analysis and shoulder reconstruction. The discriminator examiners want is that this is a basic calcium phosphate (apatite) disease, not urate or pyrophosphate.

Where candidates slip. Milwaukee shoulder overlaps clinically and radiographically with mechanical cuff tear arthropathy, so the candidate must explain the crystal-driven mechanism that sets it apart. The bloody, non-inflammatory effusion and the non-birefringent crystals are favourite traps.

The knee can be involved too, and that matters more than it first appears: this is a systemic crystal diathesis, not a purely local shoulder problem. The name Milwaukee shoulder-knee syndrome comes from the 1984 series by Halverson, McCarty and colleagues, in which the knee was involved in seven of eleven cases.

The knee pattern. BCP-driven destruction characteristically targets the lateral tibiofemoral compartment and the patellofemoral joint. It produces a rapidly destructive osteoarthritis with the same large, often blood-stained, low-cell-count effusion and the same crystal-protease mechanism as the shoulder.

The deformity gives it away. Lateral-compartment loss tends to drive a valgus knee, the opposite of the varus knee produced by medial-compartment primary osteoarthritis. A rapidly destructive valgus knee with a big, bloody, quiet effusion in an elderly woman is the knee equivalent of the Milwaukee shoulder.

Examine both. The disease is frequently bilateral and polyarticular, and both shoulders and both knees can be involved. A destructive shoulder should prompt you to examine the knees, and vice versa. Diagnosis and management at the knee mirror the shoulder pathway set out below.

The destruction in Milwaukee shoulder is enzymatic, not primarily inflammatory. BCP crystals act as a stimulus that turns the synovium into a tissue that digests its own joint.

The crystal-protease cycle. The destruction feeds itself:

1. BCP crystals deposit in cartilage, the joint capsule and the rotator cuff, often with pre-existing degeneration and a massive cuff tear.
2. Crystals are shed into the joint and phagocytosed by synoviocytes and macrophages.
3. Activated synovial cells release proteolytic enzymes, especially collagenases and other matrix metalloproteinases (MMPs), together with prostaglandins and cytokines.
4. The enzymes degrade collagen and cartilage matrix, releasing further crystals and matrix fragments.
5. The released crystals re-stimulate the synovium, creating a self-amplifying loop of crystal shedding and enzymatic destruction.

View larger

Why the effusion is bloody but quiet. Candidates often assume that "crystal arthropathy" means an acute neutrophilic flare like gout. Progressive capsular and synovial breakdown, with repeated microtrauma against a deficient cuff, does produce a large, blood-stained effusion. But the dominant mechanism is protease-mediated matrix digestion rather than a neutrophil-driven inflammatory flare, so the synovial white cell count remains low, with mononuclear cells predominating.

The mechanical contribution. A massive or complete rotator cuff tear removes the depressing force couple, and the humeral head migrates superiorly. The head erodes the undersurface of the acromion (acetabularization) and is itself rounded off (femoralization). In Milwaukee shoulder the crystal-protease cycle accelerates this destruction.

Milwaukee shoulder sits at the destructive extreme of a continuum that runs through ordinary BCP-laden osteoarthritis. Apatite-associated osteoarthritis is one of the BCP syndromes listed under Classification, and two of the evidence cards below concern it.

Common in the osteoarthritic joint. BCP crystals are found in the synovial fluid of a high proportion of osteoarthritic joints, particularly in advanced disease. Their presence is associated with more severe radiographic change and larger effusions, and has been linked to faster progression. Calcium-containing crystals (CPPD and BCP: hydroxyapatite, carbonate-apatite and octacalcium phosphate) are the most common crystals in the osteoarthritic joint (Ea & Lioté) (DOI).

Innocent bystander or active driver? This is the genuine controversy. The crystals could be a marker of cartilage breakdown, shed from damaged cartilage and bone as an epiphenomenon, or an active driver of progression. The evidence for a pathogenic role is strong: BCP crystals injected into mouse knees induce osteoarthritis-like changes, and they activate inflammatory pathways, interleukin-6 and crystal-induced osteoclastogenesis, that degrade cartilage and resorb bone (Stack & McCarthy) (DOI). Taken to the extreme, the same protease-and-cytokine biology produces the Milwaukee shoulder.

Hard to detect. BCP crystals are non-birefringent and hard to detect, so their role in osteoarthritis is under-recognised. Dual-energy CT (DECT) is emerging as a non-invasive way to quantify intra-articular calcium-crystal deposition.

No targeted treatment yet. There is still no proven crystal-targeted or disease-modifying therapy, so a BCP-laden osteoarthritic joint is managed with the same symptomatic approach. The IL-6 and osteoclast pathways are the obvious future targets.

View larger

View larger

Milwaukee shoulder belongs to the family of calcium-containing crystal diseases and to a spectrum of BCP-related musculoskeletal syndromes. Place it by crystal, by BCP syndrome and by clinical course.

By Crystal TypeBCP Disease SpectrumBy Clinical Course

The three crystals every candidate must separate:

• Monosodium urate (MSU) - gout: needle-shaped, strongly negatively birefringent. Acute, intensely inflammatory.
• Calcium pyrophosphate dihydrate (CPPD) - pseudogout: rhomboid or rod-shaped, weakly positively birefringent. Chondrocalcinosis on X-ray.
• Basic calcium phosphate (BCP) - Milwaukee shoulder and calcific tendinitis: tiny, clump-forming, non-birefringent. Requires alizarin red or electron microscopy.

View larger

The same crystal family causes three distinct problems:

• Calcific tendinitis and periarthritis: deposits in tendons and bursae (for example supraspinatus) causing acute periarticular pain, often self-limiting.
• Apatite-associated osteoarthritis: BCP crystals within osteoarthritic joints, contributing to progression.
• Milwaukee shoulder syndrome: the severe, rapidly destructive intra-articular form, and the subject of this page.

View larger

View larger

View larger

• Indolent or chronic: slowly progressive shoulder pain, weakness and recurrent effusion over months to years.
• Rapidly destructive: accelerated glenohumeral and proximal humeral destruction over weeks to a few months, with marked bone loss.
• End-stage: superior migration, acetabularization and pseudoparalysis, radiographically indistinguishable from advanced cuff tear arthropathy.

History. An elderly woman with chronic shoulder pain, often worse at night, and weakness with loss of active elevation from the underlying massive cuff tear. The shoulder swells recurrently, and patients may describe it "filling up" again and again.

Examination. There is a large effusion or fullness around the shoulder, sometimes with a fluctuant anterosuperior swelling. Active elevation is restricted and weak while passive range is relatively preserved early on. Look for the signs of a massive cuff tear, a positive drop-arm test, weak external rotation and possible anterosuperior escape; crepitus and deformity appear as destruction advances.

The bedside discriminator. Warmth is usually mild, unlike the hot, inflamed joint of sepsis or gout. The disproportion between a large, sometimes bloody effusion and a relatively quiet, non-erythematous joint points to Milwaukee rather than sepsis or gout. Female sex, advanced age and the dominant shoulder make a highly characteristic pattern.

The destroyed shoulder. A hot, swollen, destroyed shoulder in an elderly patient is septic arthritis until proven otherwise, and aspiration comes before any destruction is attributed to crystals. After sepsis, the differential runs through crystal disease, mechanical or neuropathic arthropathy, and rheumatoid or other inflammatory disease.

The figures below show three mimics: rapidly destructive shoulder arthrosis, the neuropathic (Charcot) shoulder, and rapid humeral-head collapse from bone fragility.

View larger

View larger

View larger

Aspirate the joint. Synovial fluid analysis is the key test, and aspiration is both diagnostic and therapeutic. Always send the fluid for Gram stain, culture and a cell count to exclude septic arthritis.

The fluid. A large volume, often blood-stained or xanthochromic, with a characteristically low cell count: typically a few hundred to low thousands, mononuclear-predominant. That is a vital discriminator, very different from the high neutrophil counts of gout, CPPD or sepsis.

The crystals. BCP crystals are non-birefringent and individually too small for light microscopy; they form clumps that look like "shiny coins". A standard polarised microscopy report of "no crystals" therefore does not exclude Milwaukee shoulder, and this is the single most-tested trap.

Alizarin red S staining screens for calcium, and is a cheap, sensitive laboratory screen for BCP. A positive stain on synovial fluid is an important, inexpensive step towards the diagnosis, but alizarin red stains CPPD as well as BCP, so it narrows the field without making the diagnosis. Definitive confirmation is by electron microscopy or X-ray diffraction in specialist settings.

Plain radiographs. The findings are often indistinguishable from advanced mechanical cuff tear arthropathy:

• Superior migration of the humeral head with reduced acromiohumeral distance
• Glenohumeral joint space loss, subchondral sclerosis and rapid bone destruction or collapse of the humeral head
• Acetabularization of the acromion and femoralization of the tuberosity in end-stage disease
• Soft-tissue and intra-articular calcification may be visible

View larger

Cross-sectional imaging. Ultrasound or MRI confirms the massive rotator cuff tear, demonstrates the large effusion and synovial thickening, and assesses the remaining muscle quality before any reconstruction. CT defines bone loss and glenoid morphology when arthroplasty is being planned.

View larger

View larger

Management is predominantly conservative, escalating to arthroplasty for end-stage joints with intractable pain or loss of function. There is no proven crystal-dissolving or disease-modifying drug for BCP arthropathy, so treatment is symptomatic: conservative measures control symptoms but do not halt structural progression.

Conservative (First Line)Procedural / AdjunctsSurgical (End-Stage)

First-line treatment centres on analgesia and repeated arthrocentesis with intra-articular steroid.

• Therapeutic aspiration of the large effusion relieves symptoms and confirms the diagnosis; it may be repeated.
• Intra-articular corticosteroid after aspiration can reduce synovial activity and effusion recurrence.
• Analgesia and NSAIDs for symptom control, mindful of renal and GI risk in the elderly.
• Activity modification and physiotherapy to maintain whatever function the deficient cuff allows.

Closed-needle tidal joint irrigation (lavage) has been reported as useful, washing out crystals and debris in selected refractory cases. Arthroscopic debridement or synovectomy has a limited, palliative role and does not reverse the underlying process.

For end-stage, painful, functionally disabling joints, shoulder arthroplasty is considered. It becomes appropriate only when pain and disability are severe, infection is excluded, bone stock is adequate and the cuff is irreparable. The rotator cuff is massively deficient, so reverse total shoulder arthroplasty is the logical reconstruction: it does not rely on the cuff and restores a stable fulcrum, as in the management of cuff tear arthropathy. Anatomic total shoulder arthroplasty is generally unsuitable given the cuff deficiency and superior migration.

The older therapeutic review by Epis and colleagues says total shoulder arthroplasty may be considered; that recommendation predates the general adoption of reverse arthroplasty for the cuff-deficient shoulder. Beyond those conditions, patient selection must weigh age, comorbidity, bone stock and functional goals.

View larger

Complications. Most follow from the disease itself; the last belongs to the reconstruction.

• Progressive joint destruction with chronic pain and loss of function, and pseudoparalysis once the cuff and fulcrum fail
• Recurrent large effusions requiring repeated aspiration
• Massive irreparable cuff tear with anterosuperior escape
• Rapid humeral head collapse in the aggressive variant
• After reverse arthroplasty, the standard prosthetic risks: instability, scapular notching, infection and glenoid loosening

Prognosis. The natural history is one of slow but relentless destruction over months to years, occasionally punctuated by rapid deterioration. Reverse total shoulder arthroplasty offers reliable pain relief and improved function in carefully selected end-stage patients. The focus is symptom control and timely arthroplasty rather than cure.

Milwaukee shoulder is a rare condition without dedicated international management guidelines; practice is guided by rheumatology consensus on crystal arthropathies and by shoulder arthroplasty evidence.

Diagnostic Consensus (Global Rheumatology Practice)

• Synovial fluid analysis is the cornerstone worldwide: cell count plus crystal identification, with alizarin red S as the accessible screen for calcium (BCP) crystals because they are non-birefringent.
• Confirmation by electron microscopy / X-ray diffraction is reserved for specialist or research settings, reflecting limited availability globally.

Management Principles

• International rheumatology guidance for calcium crystal disease emphasises symptomatic treatment - analgesia, aspiration and intra-articular corticosteroid - as there is no disease-modifying therapy for BCP crystals.
• For end-stage destruction with an irreparable cuff, shoulder arthroplasty guidance (AAOS, BOA/BESS in the UK, and international shoulder societies) supports reverse total shoulder arthroplasty as the reconstruction of choice when the cuff is deficient.

Registry Evidence (Shoulder Arthroplasty)

• National joint registries (e.g. AOANJRR in Australia, NJR in the UK, AJRR in the US) report rising reverse total shoulder arthroplasty volumes for cuff-deficient destructive arthropathies, with reverse designs showing durable pain relief; scapular notching and instability are the implant-specific concerns tracked over time.
• Milwaukee shoulder is typically captured within the broader cuff tear arthropathy / massive cuff tear indication rather than as a separate registry category, so disease-specific survivorship data are limited.

• BCP (Milwaukee) crystals are non-birefringent - polarised light will not show them. Alizarin red S screens for calcium but stains CPPD too; electron microscopy or X-ray diffraction is what confirms.
• The shoulder effusion is large and bloody but has a LOW cell count (non-inflammatory).
• Destruction is enzymatic - synovial collagenases / MMPs stimulated by crystals.
• Elderly woman, dominant shoulder, massive cuff tear is the classic triad.
• Management is conservative first (aspiration, steroid, irrigation); reverse TSA for end-stage.
• Always exclude septic arthritis before attributing a destroyed shoulder to crystals.

Related pages: Rotator Cuff Arthropathy and Massive Rotator Cuff Tears for the cuff-deficient shoulder this syndrome sits inside, and Reverse Total Shoulder Arthroplasty for the reconstruction it ends in; Pseudogout (CPPD Disease) and Gout for the two crystals that must be separated from this one; Calcific Periarthritis (Hydroxyapatite Deposition) and Calcific Tendinitis of the Shoulder for the periarticular end of the same BCP spectrum; and Septic Arthritis for the exclusion that comes first.